How we can help
Business success from business sense
Our purpose is to make our clients successful. Highly defensible breakthrough innovation that creates sustainable businesses and disrupts markets is what defines us – but we operate well beyond the boundaries of technology. It’s a point of pride that we’ve built commercially experienced, market astute and business savvy teams. We hire people who speak the language of a start-up, where every dollar of investment expects a return.
The experience necessary to push limits
The higher the risk, the greater the reward and this characterises much of the work we do. Our clients want to push the limits of what was thought possible. We are well tuned to guiding the bold, creative ambition of start-ups, and have a long track record of robust project management and successful delivery.
The value of knowledge and IP
All intellectual property (IP) that we generate on a project will be passed to you as our client, creating value for you and your investors. Additional value comes from our knowledge transfer and close interworking, which helps up-skill your business with the results of the project. We can also support the hiring of key staff, helping you build your team.
Process rigour and flexible deployment
Many start-ups lack their own R&D capability and processes in the early stages, but those that work with us immediately benefit from the proven, robust and agile methods we’ve developed over many years. You’ll be able to tackle development, regulatory approvals and new product introduction with confidence – and get to market faster with less risk. We’ll focus on working with you to help meet milestones for onward funding and be flexible in our team deployment to meet the resultant investment profile.
캠브리지 컨설턴트와 웨이맵은 대중교통 중심지와 같은 복잡한 실내 공간 안에서 시각 장애인들에게 길을 안내하는 혁신적인 스마트폰 서비스를 개발하였다.
- 머신 러닝 & AI
- 디지털 서비스
- 추적 & 위치
A world-first for endovascular bleed detection
- 디지털 헬스
- 인간 공학
- 산업 디자인
Enabling the world's first DNA-based platform for massive data storage
확장형 고충실도(high-fidelity) 신속 유전자 합성용 데스크탑 플랫폼을 개발하는 합성 바이오 기업 에보네틱스는 오늘 시리즈 B 투자 유치에 성공했다고 발표했다.